Examples
| Generic Name | Brand Name |
|---|
| tissue plasminogen activator (t-PA) or alteplase | Activase |
How It Works
Tissue plasminogen activator (t-PA)
dissolves blood clots.
Why It Is Used
Tissue plasminogen activator can be
used to treat some people who are having a
stroke caused by a blood clot (ischemic stroke
). It is
given in a vein (intravenously, or IV) and in some cases may be given directly
into an artery.
The medicine should be given within 3 hours after
stroke symptoms begin. Strict criteria must be met in order to use the
medicine. The medicine can be used to prevent disability after a stroke.
Who should not take t-PA
T-PA dissolves blood clots, so giving it to someone who has bleeding in the
brain can be life-threatening. A computed tomography (CT) scan of the head must
be done before giving the medicine, to make sure there is no bleeding present
in the brain.
People who have had prior bleeding problems, recent
surgery, or have problems with blood clotting cannot take t-PA. Very high blood
pressure, a recent bleeding ulcer, or brain cancer are other reasons not to use
t-PA.
How Well It Works
Studies have shown that:
- T-PA helped people with strokes caused by clots
(ischemic strokes) when it was given within 3 hours after stroke symptoms
began.
- T-PA did not decrease the chance of having another stroke in
the future.
Side Effects
Bleeding is a major side effect of
tissue plasminogen activator. If t-PA is given to a person who has had bleeding
within the brain, it increases the risk for bleeding into the brain, which
increases the chance of death. This makes it very important to distinguish
whether a person's stroke is caused
by a clot or by a bleeding blood vessel
before giving the medicine. Before this
medicine is given, computed tomography (CT) scan of the head is used to make
sure there is no bleeding inside the brain.
See Drug Reference for
a full list of side effects. (Drug Reference is not available in all
systems.)
What To Think About
Tissue plasminogen activator
should be given within the first 3 hours after the first symptoms of stroke
start. The person and/or family members need to provide as much information as
possible about what symptoms the person had and when they began. This helps
determine whether giving t-PA would be helpful. If symptoms have gone on for
more than 3 hours, the medicine is unlikely to benefit the person. Other strict
criteria also must be met before the medicine can be given.
Most
people who might benefit from the use of t-PA cannot get the medicine because
they do not go to the hospital soon enough (within 3 hours after the start of
symptoms). But evidence shows that there may be some benefit in giving t-PA
even beyond 3 hours.1, 2, 3
Before you are given
t-PA, the doctor must explain its risks and benefits to you. You may need to
sign a consent form before you take it.
T-PA should never be given
to a person who has had a stroke caused by bleeding (hemorrhagic stroke).
Before this medicine is given, a
computed tomography (CT) scan of the head can help
make sure there is no bleeding in the brain. A CT scan may also be done to look
for damage caused by a blood clot that has blocked blood supply to part of the
brain (ischemic stroke).
Medicines that interfere with normal
clotting (anticoagulants or antiplatelets, such as aspirin) should not be used
for 24 hours after receiving t-PA.
A CT scan of the head is
usually repeated 24 hours after the medicine is given.
T-PA should
be given only in hospitals that are equipped to take care of bleeding
complications that this medicine may cause.
Complete the new medication information form (PDF)
(What is a PDF document?) to help you understand this medication.